Class I Recall

Boulla LLC

Product
PeakMax Capsules, 500 mg, packaged in 10 count blisters in cartons, Distributed by: PeakMax, San Francisco, CA, www.PeakMax.com
Reason
Marketed without an approved NDA/ANDA: Products found to contain undeclared sildenafil and diclofenac.
Classification
Class I
Status
Ongoing
Lot
Lot #: 230811, Exp: 08/11/2025
Date
Disclaimer: This tool indexes published US FDA drug-enforcement recall records from all countries, limited to the latest five years. A company or product not appearing here is not proof that it is compliant, approved, safe, or free of FDA action.
Boulla LLC — Class I Recall | MedicineWatch US